Summit Therapeutics Inc.
SMMT
Classement en actions
#1658
Summit Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering,... Summit Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing therapeutic solutions, primarily targeting infectious diseases across the United States and Latin America. The company's clinical development pipeline is heavily concentrated on therapies for Clostridioides difficile infection (CDI). Its flagship product candidate, ridinilazole, is an orally administered small molecule antibiotic currently advancing through Phase III clinical trials as a treatment for CDI. Beyond its lead asset, Summit Therapeutics is also progressing SMT-738, designed to combat multidrug-resistant infections, notably carbapenem-resistant Enterobacteriaceae (CRE). Additionally, its DDS-04 series represents a potential therapeutic avenue for various infections caused by the Enterobacteriaceae family of bacteria. Established in 2003, the company maintains its headquarters in Cambridge, Massachusetts.
Prix de l'action
$16.14
Dernière synchronisation: 2026-10-20
Capitalisation boursière
$12.87B
Changement (1 jour)
3.65%
Changement (1 an)
-13.88%
Pays
US
Échange Summit Therapeutics Inc. (SMMT)
Catégorie
Healthcare
Historique des divisions d’actions pour Summit Therapeutics Inc. (SMMT)
L’action Summit Therapeutics Inc. (symbole : SMMT) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Oct 21, 2026.
Une action SMMT achetée avant le Oct 21, 2026 équivaudrait aujourd’hui à 0 actions SMMT.
La division la plus récente a eu lieu le Oct 21, 2026.
Une action SMMT achetée avant le Oct 21, 2026 équivaudrait aujourd’hui à 0 actions SMMT.
Liste des divisions d’actions
| Année | Division | Multiplicateur | Multiplicateur cumulatif |
|---|---|---|---|
| Pas assez de données pour les dates fournies. | |||
Divisions d’actions d’entreprises similaires ou concurrentes
| Entreprise | Nombre de divisions d’actions | Multiplicateur cumulatif | Pays |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
